Notice of Applicant Information Webinar for RFA-DA-19-013, "Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional)"

Notice Number: NOT-DA-18-052

Key Dates
Release Date:October 10, 2018

Related Announcements
RFA-DA-19-013   

Issued by
National Institute on Drug Abuse (NIDA)

Office of Behavioral and Social Sciences Research (OBSSR)

Tribal Health Research Office (THRO)

Purpose

This Notice is to inform potential applicants to RFA-DA-19-013 of a pre-application webinar to provide submission information for the NIDA's "Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional)". The intent of the webinar is to provide an overview of the initiative and to address questions pertinent to preparing applications. The webinar is optional and not required for application submission.

Webinar Information:
Date: Tuesday, October 16, 2018
Time: 4:00 pm ET

NIDA staff will post information about how to participate in the Webinar at https://www.drugabuse.gov/news-events/meetings-events/2018/10/rfa-technical-assistance-webinar-responding-to-opioid-use-disorders-oud-in-tribal-communities-in.  Prospective applicants are encouraged to submit their questions or comments regarding the RFA to ketz@nih.gov by October 15, 2018.  Following the webinar, NIDA will post the slides presented during the Webinar on the same website.  Prospective applicants with inquiries concerning the FOA who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar. 

Inquiries

Please direct all inquiries to:

Kathy Etz, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1749
Email: ketz@nih.gov